Thermo Fisher Scientific opens viral vector manufacturing facility in Plainville, Massachusetts.
Search Patheon
Search
US | EN
Under pressure to maximize productivity and to reduce the time and cost of shepherding new drugs from laboratory through licensure, the biopharmaceutical industry has continued to globalize the clinical trial footprint over the past 15 years. While an enlarged clinical trial universe certainly benefits patient recruitment and diversity, it also multiplies the operational and strategic obstacles that clinical trial professionals must circumvent.
Download this fact sheet to learn how despite the substantial progress being made toward global regulatory alignment, customs requirements continue to evolve and may differ significantly amongst even neighboring countries.